1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
Bei Chen(Genomics Institute of the Novartis Research Foundation), Zhangjian Huang(Xinjiang Medical University), Jianhua Yang(Xinjiang Medical University), Huijing Gao(Xinjiang Medical University), Jianhua Wang(Dalian Ocean University), Jianbing Wu(China Pharmaceutical University), Jingxuan Pan(Heilongjiang Bayi Agricultural University), Yong Ling(Nantong University), Yun Liu(Shandong Provincial Hospital), Zhengsheng Yan(China Pharmaceutical University), Hao Wen(Xinjiang Medical University), Yihua Zhang(China Pharmaceutical University), Jun Zhao(Nanjing Medical University), Hongmei Wu(Nantong University)
Cited by 13
Related Papers
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
|Drug Design Development and Therapy|2021|377
Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species
|Cancer Research|2010|332
Carbon-based quantum dots for fluorescence imaging of cells and tissues
|RSC Advances|2014|329
Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases
|Hepatology International|2020|130